A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(4 sites)

United States

UCLA Medical Center, Los Angeles, California

Rady Children's Hospital, San Diego, California

ECU Brody School of Medicine, Greenville, North Carolina

University of Texas Medical Branch at Galveston, Galveston, Texas